An explosive Reuters investigation revealed Friday that a series of executions the Trump administration has planned for next week “will mark the culmination of a three-year campaign to line up a secret supply chain to make and test lethal injection drugs.”
The U.S. Supreme Court on June 29 cleared the way for federal executions to resume when it denied to hear an appeal from death row prisoners challenging the Trump administration’s lethal injection protocol. Inmates Daniel Lewis Lee, Wesley Ira Purkey, and Dustin Lee Honken are set to be killed at a federal facility in Indiana just days apart beginning on July 13, followed by Keith Dwayne Nelson on August 28.
Although it wasn’t until July 2019 when U.S. Attorney General William Barr publicly directed the Bureau of Prisons to resume capital punishment using only the drug pentobarbital—in lieu of a three-drug protocol that had been hampered by supply issues—Reuters reported that “President Donald Trump’s Department of Justice had started building the network of contractors it would need by May 2017.”
A look at how the Trump administration secured a secret supply of execution drugs, despite FDA-approved pharmaceutical companies refusing to sell them to the Department of Justice https://t.co/Xb0JJ4J2e5 pic.twitter.com/QGbHNRnmmP
— Reuters (@Reuters) July 10, 2020
Based on government records and court filings, Reuters detailed steps the administration took before Barr’s announcement to resume federal executions.
In May 2017, the Justice Department reportedly hired the Arizona consulting firm Elite Medical Experts LLC to find “physicians and scientists who could assess whether pentobarbital was a humane method of execution that could replace the three-drug lethal injection protocol used in the last federal execution in 2003.”
According to the news agency:
Since then, [the administration] has pursued a new drug protocol that could survive legal challenges through firms whose identities it has fought to keep hidden. Without the secrecy, the government has argued in court filings, its ability to procure the drugs would be “severely impaired” because the companies are not willing to supply or test execution drugs if they are publicly identified.
The government documents showed that by March 2018, the Justice Department found a compounding pharmacy to make an injectable pentobarbital. By October 2018, the department found a manufacturer of pentobarbital powder, and by February 2019, the manufacturer was producing powder that “passed purity tests,” after initially failing such assessments.
Representatives for all three laboratories that Reuters identified as involved in pentobarbital testing said they were hired by a compounding pharmacy rather than the Justice Department. DynaLabs in St. Louis and ARL Bio Pharma Inc in Oklahoma City also told the news agency they did not know the intended use of the drugs while Eagle Analytical Services Inc. in Houston declined to comment.
A department spokesperson declined to disclose to Reuters any details related to the administration’s efforts to secure drugs for lethal injections.
The death penalty has no place in the United States.
Our federal and state justice systems should not kill anyone for any reason. https://t.co/J0PKY0DWHb
— The Leadership Conference (@civilrightsorg) July 10, 2020
Although the last execution of a federal inmate was in 2003, states that still allow capital punishment have continued to kill inmates the past 17 years, despite also facing barriers to accessing the necessary drugs. Texas, which leads all states in executions, has used pentobarbital alone to kill prisoners in recent years.
As the Associated Press reported in November 2018:
Some past executions have raised questions about the use of pentobarbital. In Texas, an inmate put to death in July cursed twice and said the drug burned his throat. An inmate executed in June started taking quick breaths as the sedative started to take effect, muttering at one point that it was “burning” and that it “hurt.” Before that, a Texas inmate said the drug burned. “Oooh-ee! I can feel that,” he said before slipping into unconsciousness.
Since Barr’s July 2019 announcement, critics have raised concerns about the Trump administration using the drug. As Sam Spital, director of litigation for the NAACP Legal Defense and Educational Fund, told TIME a few days after the attorney general’s order: “Nobody knows if the pentobarbital that the government has obtained will address the serious risks that individuals across the country are facing of being tortured to death through lethal injection.”
We’re not backing down in the face of Trump’s threats.
As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.
Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.
As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.
At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.
Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.
You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.